Market Research and Statistics

Global Continuous Glucose Monitoring Systems Market, by Component

Press Release   •   Jan 11, 2018 00:43 EST

According to a new report, “Global Continuous Glucose Monitoring Systems (CGMS) Market (2016-2022)”, published by KBV Research, the Global Continuous Glucose Monitoring Systems Market is expected to reach $3.6 billion by 2022, growing at a CAGR of 28.2% during 2016 -2022.The North America market dominated the Global Continuous Glucose Monitoring Systems Market in 2015, and would grow at a CAGR of 28.1% during the forecast period. However, Asia-Pacific market is expected to grow at CAGR of 32% during 2016-2022.

The Sensors market contributed the larger revenue share to the Global Continuous Glucose Monitoring Systems Market in 2015, and is expected to grow at a CAGR of 31% during the forecast period. The Transmitters & Receivers market is expected attain a market size of $703 million by 2022.

The Diagnostic centers/clinics market registered the largest revenue share in the Global Continuous Glucose Monitoring Systems Market in 2015, and would reach a market size of $1.6 billion by 2022, growing at a CAGR of 27.4% during the forecast period. The Home Healthcare market is expected to grow at CAGR of 42% during 2016-2022.

The report highlights the adoption of Continuous Glucose Monitoring Systems, globally.Based on the Component, the Global Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The geographiesincluded in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Full report: http://kbvresearch.com/global-continuous-glucose-monitoring-systems-market/

Research Scope

The market is segmented based on Component, End User and Geography.

Global Continuous Glucose Monitoring Systems Market, by Component

  • Hardware
  • Software
  • Services

Global Continuous Glucose Monitoring Systems Market, by End User

  • Displays Terminals
  • Interface Software
  • Industrial PCs
  • Other Controllers

Global Continuous Glucose Monitoring Systems Market, by Geography

  • North America
    • U.S
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Company Profiles

  • Roche Diagnostics
  • Abbott Laboratories
  • Dexcom Inc.
  • Novo Nordisk
  • Ypsomed AG
  • GlySens Incorporated
  • Medtronic Plc and
  • Johnson & Johnson

Related Reports-

Europe Continuous Glucose Monitoring Systems Market

Asia Pacific Continuous Glucose Monitoring Systems Market

North America Continuous Glucose Monitoring Systems Market

Lamea Continuous Glucose Monitoring Systems Market

Market Research & Statistics (MRAS) is a Market Research brand owned solely by Marqual IT Solutions Pvt. Ltd., an India based IT company. With years of experience in the research field, we have gained grass root knowledge about the gaps prevailing within the research industry. With innovative products and solutions such as Market Research and Analytics Tool, Sales intelligence reports, R&D intelligence, Industry wide Investment trends, etc. we are growing to be a leading Market Research Company within the landscape of Market Research sector. Each of our innovative products is offered through individualistic brand name and with Market Research & Statistics, we specialize in publisher model.